DOI:
10.1055/s-00034612
Yearbook of Medical Informatics
LinksClose Window
References
Domchek SM, Aghajanian C, Shapira-Frommer R, Schmutzler RK, Audeh MW, Friedlander M. , et al.
Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy.
Gyn Onc 2016;
140 (02) 199-203
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.